3-(4,4,4-trifluoro-3-hydroxybut-2-enoyl)benzonitrile, 95%, 250mg

5-Ethyl-2,4-dimethyl-2H-pyrazol-3-ylamine, 95.0%, 10g

4-(3,3-Difluoropyrrolidin-1-yl)piperidine dihydrochloride, 95+%, 250mg

3-Fluorocyclobutanecarboxylic acid, 95.0%, 1g

Nazartinib, 50mg

N,N-Dimethyl-1-(morpholin-2-yl)methanamine dihydrochloride, 95.0%, 500mg

6-Bromo-N-ethyl-[1,2,4]triazolo[4,3-a]pyridin-3-amine, 95.0%, 250mg

1,3-Diphenylacetone p-Toluenesulfonylhydrazone>98.0%(HPLC)(T)10g

2',3'-dihydro-spiro[cyclobutane-1,4'(1'H)-isoquinoline] hydrochloride, 97.0%, 250mg

1-(3-(Trifluoromethoxy)phenyl)ethanamine, 97%, 2.5g

4,4'-Diethynyl-2,2'-bipyridine, 97%, 100mg

3-Bromo-1-(2,6-difluorophenyl)pyrrolidin-2-one, 95%, 50mg

Monosodium Bromoisocyanurate>87.0%(T)25g